The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter How did BPC 157 become the wellness industry's star peptide?